Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Ovarian Neoplasms Malignant · Ascites

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China
Contact: Study coordinator (Ning Li, MD) · cancergcp@163.com · 8610-87787210
Contact: Principal Investigator (Ning Li, MD)

Study leads

Ning Li, MD
Principal Investigator
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

Ovarian Neoplasms

Abroad (travel likely)RecruitingPHASE3

Randwick, Australia · Montreal, Canada

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Solid Tumor, Adult · Colorectal Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Gilbert, United States · Phoenix, United States